臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pin nan"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 16-39 / 39 (共1页)
1
每页显示[10|25|50]项目

机构	日期	题名	作者
國立成功大學	2023-02	Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents	Cheng;Pin-Nan;Sun;Hung-Yu;Feng;I-Che;Chiu;Yen-Cheng;Wang;Sin-Tian;Tan;Charmaine, Dyoness;Chiu;Hung-Chih;Chien;Shih-Chih;Young;Kung-Chia
國立成功大學	2022-12	Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial	Cheng;Pin-Nan;Liu;Chun-Jen;Chen;Chi-Yi;Tseng;Kuo-Chih;Lo;Ching-Chu;Peng;Cheng-Yuan;Lin;Chih-Lin;Chiu;Hung-Chih;Chiu;Yen-Cheng;Chen;Pei-Jer
國立成功大學	2022-11	Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection	Chien;Shih-Chieh;Lin;Yih-Jyh;Lee;Chun-Te;Chiu;Yen-Cheng;Chou;Tsung-Ching;Chiu;Hung-Chih;Tsai;Hung-Wen;Su;Che-Min;Yang;Tsung-Han;Chiang;Hsueh-Chien;Tsai;Wei-Chu;Yang;Kai-Chun;Cheng;Pin-Nan
國立成功大學	2022-11	Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/ pibrentasvir for genotype 6 chronic hepatitis C	Chen;Jyh-Jou;Chiu;Yen-Cheng;Lee;Pei-Lun;Tung;Hung-Da;Chiu;Hung-Chih;Chien;Shih-Chieh;Cheng;Pin-Nan
國立成功大學	2022-05	Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral	Huang;Shang-Chin;Cheng;Pin-Nan;Liu;Chen-Hua;Yang;Hung-Chih;Su;Tung-Hung;Tseng;Tai-Chung;Chen;Pei-Jer;Kao;Jia-Horng;Liu;Chun-Jen
國立成功大學	2021-07	Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis	Tsai;Hong-Ming;Han;Meng-Zhi;Lin;Yih-Jyh;Chang;Ting-Tsung;Chen;Chiung-Yu;Cheng;Pin-Nan;Chuang;Chiao-Hsiung;Wu;I-Chin;Chen;Po-Jun;Kang;Jui-Wen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Chien;Shih-Chieh;Kuo;Hsin-Yu
國立成功大學	2021-06	Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss	Wu;I-Chin;Liu;Wen-Chun;Chiu;Yen-Cheng;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung
國立成功大學	2021-03	Effectiveness and safety of ledipasvir/ sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan	Chiu;Hung-Chih;Chiu;Yen-Cheng;Yang;Er-Hsiang;Chang;Ting-Tsung;Chien;Shih-Chieh;Wu;I-Chin;Wu;Chun-Hsien;Cheng;Pin-Nan
國立成功大學	2021-01	Persistent augmentation of central arterial stiffness following viral clearance by direct-acting antivirals in chronic hepatitis C	Chen;Ju-Yi;Cheng;Pin-Nan;Chiu;Yen-Cheng;Chiu;Hung-Chih;Tsai;Wei-Chuan;Tsai;Liang-Miin
國立成功大學	2020-07	Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry	Wu;Hsin-Yi;Pan;Yu-Yi;Kopylov;Arthur, T.;Zgoda;Victor;Ma;Mi-Chia;Wang;Ching-Hsun;Su;Wu-Chou;Lai;Wu-Wei;Cheng;Pin-Nan;Liao;Pao-Chi
國立成功大學	2020-05	Limited drug-drug interaction of elbasvir/grazoprevir for chronic hepatitis C	Liu;Chun-Jen;Tseng;Kuo-Chih;Lo;Ching-Chu;Tseng;I-Hao;Cheng;Pin-Nan
國立成功大學	2020-04	Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients	Liu;Wen-Chun;Wu;I-Chin;Chiu;Yen-Cheng;Tseng;Kuo-Chih;Chen;Chi-Yi;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung
國立成功大學	2020-03	Real-world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in Taiwan	Chen;Jyh-Jou;Lee;Pei-Lun;Chiu;Hung-Chih;Tung;Hung-Da;Chiu;Yen-Cheng;Cheng;Pin-Nan
國立成功大學	2019-11	Insulin Resistance Associated Disorders Pivoting Long-Term Hepatitis B Surface Antigen Decline During Entecavir Therapy	Lin;Tien-Ching;Liu;Wen-Chun;Hsu;Yu-Hsiang;Lin;Jia-Jhen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Cheng;Pin-Nan;Chen;Chiung-Yu;Chang;Ting-Tsung;Wu;I-Chin
國立成功大學	2019-05	Real-world effectiveness and safety of sofosbuvir plus daclatasvir with or without ribavirin for genotype 2 chronic hepatitis C in Taiwan	Cheng;Pin-Nan;Chiu;Yen-Cheng;Chien;Shih-Chieh;Chiu;Hung-Chih
國立成功大學	2019-02-5	Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients	Cheng;Pin-Nan;Chen;Ju-Yi;Chiu;Yen-Cheng;Chiu;Hung-Chih;Tsai;Liang-Miin
國立成功大學	2019	Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study	Chien;Shih-Chieh;Chen;Chiung-Yu;Cheng;Pin-Nan;Liu;Yi-Shan;Cheng;Hsiu-Chi;Chuang;Chiao-Hsiung;Chang;Ting-Tsung;Chiu;Hong-Chi;Lin;Yih-Jyh;Chiu;Yen-Cheng
國立成功大學	2018-11-7	Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community	Cheng;Pin-Nan;Chiu;Hung-Chih;Chiu;Yen-Cheng;Chen;Shu-Chuan;Chen;Yi
國立成功大學	2018-07	Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection	Sun;Hung-Yu;Cheng;Pin-Nan;Tseng;Chiung-Ying;Tsai;Wei-Jen;Chiu;Yen-Cheng;Young;Kung-Chia
國立成功大學	2018-03-14	Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma	Tsai;Hung-Wen;Ho;Chung-Liang;Cheng;Shu-Wen;Lin;Yih-Jyh;Chen;Chou-Cheng;Cheng;Pin-Nan;Yen;Chia-Jui;Chang;Ting-Tsung;Chiang;Po-Min;Chan;Shih-Huang;Ho;Cheng-Hsun;Chen;Shu-Hui;Wang;Yi-Wen;Chow;Nan-Haw;Lin;Jou-Chun
國立成功大學	2018-02-22	The characteristics of residents with unawareness of hepatitis C virus infection in community	Cheng;Pin-Nan;Chiu;Yen-Cheng;Chiu;Hung-Chih;Chien;Shih-Chieh
國立成功大學	2018-02-14	Clinical utility of hepatitis B surface antigen kinetics in treatment-naive chronic hepatitis B patients during long-term entecavir therapy	Lin;Tien-Ching;Chiu;Yen-Cheng;Chiu;Hung-Chih;Liu;Wen-Chun;Cheng;Pin-Nan;Chen;Chiung-Yu;Chang;Ting-Tsung;Wu;I-Chin
國立成功大學	2017-10	Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus	Liu;Wen-Chun;Wu;I-Chin;Lee;Yen-Chien;Lin;Chih-Peng;Cheng;Ji-Hong;Lin;Yih-Jyh;Yen;Chia-Jui;Cheng;Pin-Nan;Li;Pei-Fu;Cheng;Yi-Ting;Cheng;Pei-Wen;Sun;Koun-Tem;Yan;Shu-Ling;Lin;Jia-Jhen;Yang;Jui-Chu;Chang;Kung-Chao;Ho;Cheng-Hsun;Tseng;Vincent, S.;Chang;Bill, Chia-Han;Wu;Jaw-Ching;Chang;Ting-Tsung
國立成功大學	2017-05-16	Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg- positive Patients with High Serum Fucosyl- Agalactosyl IgG	Ho;Cheng-Hsun;Tsai;Hung-Wen;Lee;Chen-Yeh;Huang;Li-Juan;Chien;Rong-Nan;Wu;I-Chin;Chiu;Yen-Cheng;Liu;Wen-Chun;Cheng;Pin-Nan;Chang;Ting-Tsung;Chen;Shu-Hui

显示项目 16-39 / 39 (共1页)
1
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51269386 在线人数 : 662 教育部委托研究计画计画执行:国立台湾大学图书馆